Profiling transcription factor sub-networks in type I interferon signaling and in response to SARS-CoV-2 infection

References

[1] Stark, G. R., Kerr, I. M., Williams, B. R., et al. How cells respond to interferons. (1998). Annu Rev Biochem; 67, 227-264.10.1146/annurev.biochem.67.1.227Search in Google Scholar

[2] Park, A., Iwasaki, A. (2020). Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19. Cell Host Microbe, 27, 870-87810.1016/j.chom.2020.05.008Search in Google Scholar

[3] Platanias, L. (2005) Mechanisms of type- I- and Type-II-interferon-mediated signaling. Nature Rev Immunol, 5, 375-386.10.1038/nri1604Search in Google Scholar

[4] Weber, F., Haller, O. Viral suppression of the interferon system. (2007) Biochimie, 8, 836-842.10.1016/j.biochi.2007.01.005Search in Google Scholar

[5] Der, S. D., Zhou, A., Williams, B. R., Silverman, R. H. (1998). Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A; 95, 15623-15628.10.1073/pnas.95.26.15623Search in Google Scholar

[6] Stark, G. R., Darnell, J. E. Jr. The JAK-STAT pathway at twenty. Immunity, 36, 503-514.10.1016/j.immuni.2012.03.013Search in Google Scholar

[7] Waddell, S. J., Popper, S. J., Rubins, K. H, et al. (2010). Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One, 5, e9753.10.1371/journal.pone.0009753Search in Google Scholar

[8] Mostafavi, S., Yoshida, H., Moodley, D., LeBoité, H., Rothamel, K., et. al. (2016). Immunological Genome Project Consortium. Parsing the Interferon Transcriptional Network and Its Disease Associations. Cell, 164, 564-578.10.1016/j.cell.2015.12.032Search in Google Scholar

[9] Gongora, R., Stephan, R. P., Schreiber, R. D., Cooper M. D. (2000) Stat-1 is not essential for inhibition of B lymphopoiesis by type I IFNs. J Immunol, 165, 2362-2366.10.4049/jimmunol.165.5.2362Search in Google Scholar

[10] Gongora, R., Stephan, R.P., Zhang, Z., Cooper, M. D. (2001) An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons. Immunity, 14, 727-737.10.1016/S1074-7613(01)00152-2Search in Google Scholar

[11] Meraz, M. A., White, J. M., Sheehan, K. C., Bach, E. A., et. al. (1996). Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell, 84, 431-442.10.1016/S0092-8674(00)81288-XSearch in Google Scholar

[12] Durbin, J. E., Hackenmiller, R., Simon, M. C., Levy, D. E. (1996). Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell, 84, 443-450.10.1016/S0092-8674(00)81289-1Search in Google Scholar

[13] Gil, M.P., Bohn, E., O’Guin, A. K., Ramana, C. V. et. al. (2001). Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci U S A, 98, 6680-6685.10.1073/pnas.111163898Search in Google Scholar

[14] Wang, J., Schreiber, R. D, Campbell, I. L. (2002). STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system. Proc Natl Acad Sci U S A, 99, 16209-16214.10.1073/pnas.252454799Search in Google Scholar

[15] Ousman, S. S., Wang, J., Campbell, I. L. (2005). Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J Virol, 79, 7514-7527.10.1128/JVI.79.12.7514-7527.2005Search in Google Scholar

[16] Kohlmeier, J. E., Woodland, D. L. (2009). Immunity to respiratory viruses. Annu Rev Immunol, 27, 61-82.10.1146/annurev.immunol.021908.132625Search in Google Scholar

[17] Ardain, A., Marakalala, M. J., Leslie, A. (2020). Tissue-resident innate immunity in the lung. Immunology, 159, 245-256.10.1111/imm.13143Search in Google Scholar

[18] Cui, J., Li, F., Shi Z. L. (2019). Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol, 17, 181-192.10.1038/s41579-018-0118-9Search in Google Scholar

[19] Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L. et. al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579, 270–273.10.1038/s41586-020-2012-7Search in Google Scholar

[20] Huang, C., Wang, Y., Li, X., et. al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395, 497–506.10.1016/S0140-6736(20)30183-5Search in Google Scholar

[21] Zhang, Q., Bastard, P., Liu Z, Le Pen, J., Moncada-Velez M, et. al. (2020). Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science, 370, eabd457010.1126/science.abd4570Search in Google Scholar PubMed PubMed Central

[22] Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., et. al. (2020). Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science, 370(6515)Search in Google Scholar

[23] Pairo-Castineira, E., Clohisey, S., Klaric, L., Bretherick, A.D., et. al. (2020). Genetic mechanisms of critical illness in Covid-19. Nature. doi: 10.1038/s41586-020-03065-y.10.1038/s41586-020-03065-ySearch in Google Scholar PubMed

[24] Ramana, C. V. (2019). Insights into the signal transduction pathways of mouse lung type II cells revealed by Transcription Factor Profiling in the transcriptome. Genomics Inform, 17(1):e8.Search in Google Scholar

[25] Ramana, C. V. (2019). Insights into functional connectivity in mammalian signal transduction pathways by pairwise comparison of protein interaction partners of critical signaling hubs. bioRxiv DOI: ?10.1101/2019.12.30.89120010.1101/2019.12.30.891200Search in Google Scholar

[26] Ramana, C. V. (2020). Regulation of early growth response-1 (Egr-1) gene expression by Stat1-independent type I interferon signaling and respiratory viruses. bioRxiv, DOI: https://doi.org/10.1101/2020.08.14.24489710.1101/2020.08.14.244897Search in Google Scholar

[27] Blanco-Melo, D., Nilsson-Payant, B.E., Liu, W. C., Uhl, S., Hoagland D., (2020). Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell, 181, 1036-1045.e9.10.1016/j.cell.2020.04.026Search in Google Scholar PubMed PubMed Central

[28] Wilk A. J., Rustagi, A., Zhao N. Q., Roque, J., (2020). A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med, 7, 1070-1076.10.1038/s41591-020-0944-ySearch in Google Scholar PubMed PubMed Central

[29] Babicki, S, Arndt, D, Marcu, A., Liang, Y., et. al. (2016). Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res, 44(W1), W147-53.10.1093/nar/gkw419Search in Google Scholar PubMed PubMed Central

[30] Huang da, W., Sherman, B. T., Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4(1), 44.10.1038/nprot.2008.211Search in Google Scholar PubMed

[31] Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., Morishima, K. (2017). KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res, 45, D353-D361.10.1093/nar/gkw1092Search in Google Scholar PubMed PubMed Central

[32] Zhou, Y., Zhou, B., Pache, L., Chang, M., et. al. (2019). Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun, 10, 152310.1038/s41467-019-09234-6Search in Google Scholar PubMed PubMed Central

[33] Stark, C., Breitkreutz, B. J., Reguly, T., Boucher, L., Breitkreutz, A., Tyers, M. (2006). BIOGRID: a general repository for interaction datasets. Nucleic Acids Res, 34, D535-D539.10.1093/nar/gkj109Search in Google Scholar PubMed PubMed Central

[34] Szklarczyk, D., Morris, J.H., Cook, H., Kuhn, M., et. al. (2017). The STRING database in 2017. Quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 45:D362-D368.Search in Google Scholar

[35] Orii, N., Ganapathiraju, M. K. (2012). WIKI-PI: a web-server of annotated human protein-protein interactions to aid in discovery of protein function. PLoS One, 7, e49029.10.1371/journal.pone.0049029Search in Google Scholar PubMed PubMed Central

[36] Basler, C. F, García-Sastre, A. (2002). Viruses and the type I interferon antiviral system: induction and evasion. Int Rev Immunol, 2, 305-337.10.1080/08830180213277Search in Google Scholar PubMed

[37] Dupuis, S., Dargemont, C., Fieschi, C., Thomassin, N., et. al. (2001). Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science; 293, 300-303.10.1126/science.1061154Search in Google Scholar PubMed

[38] Mavrommatis, E., Fish, E. N., Platanias, L. C. (2013). The schlafen family of proteins and their regulation by interferons. J Interferon Cytokine Res, 33, 206-210.10.1089/jir.2012.0133Search in Google Scholar PubMed PubMed Central

[39] Andersson, R., Sandelin, A. (2020). Determinants of enhancer and promoter activities of regulatory elements. Nat Rev Genet, 21, 71-87.10.1038/s41576-019-0173-8Search in Google Scholar PubMed

[40] Papin, J. A., Hunter, T., Palsson, B. O, Subramaniam, S. (2005). Reconstruction of cellular signaling networks and analysis of their properties. Nat Rev Mol Cell Biol, 6, 99-111.10.1038/nrm1570Search in Google Scholar PubMed

[41] Korzus, E., Torchia, J., Rose, D.W., Xu, L., et. al. (1998). Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science, 279, 703-707.10.1126/science.279.5351.703Search in Google Scholar PubMed

[42] Zhang, J. J., Vinkemeier, U., Gu, W., Chakravarti, D., et. al. (1996). Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc Natl Acad Sci U S A, 93, 15092-15096.10.1073/pnas.93.26.15092Search in Google Scholar PubMed PubMed Central

[43] Zeng, L., Sun, Y., Xie, L., Wei, L., et. al. (2013). Construction of a novel oligonucleotide array-based transcription factor interaction assay platform and its uses for profiling STAT1 cofactors in mouse fibroblast cells. Proteomics, 13, 2377-2385.10.1002/pmic.201200521Search in Google Scholar PubMed

[44] Bulgakov, V. P, Tsitsishvili, GSh. (2013). Bioinformatics analysis of protein interaction networks: statistics, topologies, and meeting the standards of experimental biologists. Biochemistry (Mosc), 78, 1098-103.10.1134/S0006297913100039Search in Google Scholar PubMed

[45] Han, H., Cho, J. W, Lee, S., Yun, A., Kim, H., Bae, D., et. al. (2018). TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions Nucleic Acids Res, 46, D380-D386.10.1093/nar/gkx1013Search in Google Scholar PubMed PubMed Central

[46] Ashtiani, M., Salehzadeh-Yazdi, A., Razaghi-Moghadam, Z., Hennig, H., et. al. (2018). A systematic survey of centrality measures for protein-protein interaction networks. BMC Syst Biol, 12, 80.10.1186/s12918-018-0598-2Search in Google Scholar PubMed PubMed Central

[47] Kleinberg, J. (1999). Authoritative sources in a hyper-linked environment. Journal of the ACM; 46, 604-632.10.1145/324133.324140Search in Google Scholar

[48] Adelaja, A., Hoffmann, A. (2019). Signaling Crosstalk Mechanisms That May Fine-Tune Pathogen-Responsive NFκB. Front Immunol, 10, 433.10.3389/fimmu.2019.00433Search in Google Scholar PubMed PubMed Central

[49] Langevin, C., Aleksejeva, E., Passoni, G., Palha, N., Levraud, J P., Boudinot, P. (2013). The antiviral innate immune response in fish: evolution and conservation of the IFN system. J Mol Biol, 425, 4904-4920.10.1016/j.jmb.2013.09.033Search in Google Scholar PubMed

[50] Majzoub, K., Wrensch, F., Baumert, T. F. (2019). The Innate Antiviral Response in Animals: An Evolutionary Perspective from Flagellates to Humans. Viruses, 11, 758.10.3390/v11080758Search in Google Scholar PubMed PubMed Central

[51] Shaw, A. E., Hughes, J., Gu, Q., Behdenna, A., et. al. (2017). Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses. PLoS Biol, 15, e200408610.1371/journal.pbio.2004086Search in Google Scholar PubMed PubMed Central

[52] Zhang, B., Goraya, M. U., Chen, N., Xu, L.,et. al. (2020). Zinc Finger CCCH-Type Antiviral Protein 1 Restricts the Viral Replication by Positively Regulating Type I Interferon Response. Front Microbiol, 11, 1912.10.3389/fmicb.2020.01912Search in Google Scholar PubMed PubMed Central

[53] Dai, H., Yan, M., Li, Y. (2020). The zinc-finger protein ZCCHC2 suppresses retinoblastoma tumorigenesis by inhibiting HectH9-mediated K63-linked polyubiquitination and activation of c-Myc. Biochem Biophys Res Commun, 521, 533-538.10.1016/j.bbrc.2019.10.163Search in Google Scholar PubMed

[54] Ramana, C. V., Chatterjee-Kishore, M., Nguyen, H., Stark, G. R. Complex roles of Stat1 in regulating gene expression. Onco-gene, 19, 2619-2627.10.1038/sj.onc.1203525Search in Google Scholar

[55] Velichko, S., Wagner, T. C., Turkson, J., Jove, R., Croze, E. (2002). STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c. Activation of multiple STATS proceeds through the redundant usage of two tyrosine residues. J Biol Chem, 277, 35635-35641.10.1074/jbc.M204578200Search in Google Scholar

[56] Watling D, Guschin D, Müller M, Silvennoinen O, et. al. (1993). Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature, 366, 166-170.10.1038/366166a0Search in Google Scholar

[57] Karaghiosoff, M., Neubauer, H., Lassnig, C., Kovarik, P., et. al. (2000). Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity, 13, 549-560.10.1016/S1074-7613(00)00054-6Search in Google Scholar

[58] Yang CH, Murti A, Pfeffer LM. (1998). STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities. Proc Natl Acad Sci U S A, 95, 5568-5572.10.1073/pnas.95.10.5568Search in Google Scholar PubMed PubMed Central

[59] Farrar, J. D., Smith, J. D., Murphy, T. L., Leung, S., Stark, G.R., Murphy, K. M. (2000). Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2. Nat Immunol, 1, 65-69.10.1038/76932Search in Google Scholar PubMed

[60] Gadina, M., O’Shea, J. J., Biron, C. A. (2002). Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science, 297, 2063-2066.10.1126/science.1074900Search in Google Scholar PubMed

[61] Nguyen, K. B., Salazar-Mather, T. P, Dalod M. Y., Van Deusen, J. B., et. al. (2002). Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol, 169, 4279-4287.10.4049/jimmunol.169.8.4279Search in Google Scholar PubMed

[62] Matikainen, S., Sareneva, T., Ronni, T., Lehtonen, A., Koskinen, P. J, Julkunen, I. (1999). Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood, 93, 1980-1991.10.1182/blood.V93.6.1980.406k20_1980_1991Search in Google Scholar

[63] Meinke, A., Barahmand-Pour, F., Wöhrl, S., Stoiber, D., Decker, T. (1996). Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol Cell Biol, 16, 6937-6944.10.1128/MCB.16.12.6937Search in Google Scholar PubMed PubMed Central

[64] Rani, M. R., Leaman, D. W., Han, Y., Leung, S., et. al. (1999). Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositide 3-kinase. J Biol Chem, 274, 32507-32511.10.1074/jbc.274.45.32507Search in Google Scholar

[65] Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., et. al. (2003). Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet, 33, 388-391.10.1038/ng1097Search in Google Scholar

[66] Tsai, M. H, Pai, L. M, Lee, C. K. (2019). Fine-Tuning of Type I Interferon Response by STAT3. Front Immunol, 10, 144810.3389/fimmu.2019.01448Search in Google Scholar

[67] Uddin, S., Lekmine, F., Sassano, A., Rui, H., Fish, E.N., Platanias, L. C. (2003). Role of Stat5 in type I interferon-signaling and transcriptional regulation. Biochem Biophys Res Commun, 308, 325-330.10.1016/S0006-291X(03)01382-2Search in Google Scholar

[68] Pfeffer, L. M., Mullersman, J. E., Pfeffer, S. R., Murti, A., Shi, W., Yang. C. H. (1997). STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science, 276, 1418-1420.10.1126/science.276.5317.1418Search in Google Scholar PubMed

[69] Wagner, T. C., Velichko, S., Vogel, D., Rani, M. R., et. al. (2002). Interferon signaling is dependent on specific tyrosines located within the intracellular domain of IFNAR2c. Expression of IFNAR2c tyrosine mutants in U5A cells. J Biol Chem, 277, 1493-1499.10.1074/jbc.M108928200Search in Google Scholar PubMed

[70] Arunachalam, P. S., Wimmers, F., Mok, C. K. P., Perera, R. A. P. M., Scott, M. S., et. al. (2020). Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science, 369, 1210-1220.10.1126/science.abc6261Search in Google Scholar PubMed PubMed Central

[71] Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., et. al. (2020). Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature, 584, 463-469.10.1038/s41586-020-2588-ySearch in Google Scholar PubMed PubMed Central

[72] Nienhold, R., Ciani, Y., Koelzer, V.H., Tzankov, A., et. al. (2020). Two distinct immunopathological profiles in autopsy lungs of COVID-19. Nat Commun, 11, 5086.10.1038/s41467-020-18854-2Search in Google Scholar PubMed PubMed Central

[73] Xu, L., Yoon, H., Zhao, M.Q., Liu, J., Ramana, C.V., Enelow. R. I. (2004). Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells. J Immunol, 173, 721-725.10.4049/jimmunol.173.2.721Search in Google Scholar PubMed

[74] Ramana, C. V., DeBerge, M.P., Kumar, A., Alia. C.S., Durbin, J. E., Enelow, R. I. (2015). Inflammatory impact of IFN- γ in CD8+ T cell-mediated lung injury is mediated by both Stat1-dependent and – independent pathways. Am J Physiol Lung Cell Mol Physiol, 308, L650-L657.10.1152/ajplung.00360.2014Search in Google Scholar PubMed PubMed Central

[75] Verdecchia, P., Cavallini, C., Spanevello, A., Angeli, F. (2020). The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med, 76, 14-20.10.1016/j.ejim.2020.04.037Search in Google Scholar PubMed PubMed Central

[76] Imgenberg-Kreuz, J., Sandling, J. K., Björk, A., Nordlund, J., et. al. (2018). Transcription profiling of peripheral B cells in antibody-positive primary Sjögren’s syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature. Scand J Immunol, 87, e12662.10.1111/sji.12662Search in Google Scholar PubMed

[77] Imgenberg-Kreuz, J., Sandling, J. K., Almlöf, J. C, Nordlund J., et. al. (2016). Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren’s syndrome reveals regulatory effects at interferon-induced genes. Ann Rheum Dis, 75, 2029-2036.10.1136/annrheumdis-2015-208659Search in Google Scholar PubMed PubMed Central

[78] Silvin, A., Chapuis, N., Dunsmore, G., Goubet, A. G., et. al. (2020). Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. Cell, 182, 1401-1418.e18.10.1016/j.cell.2020.08.002Search in Google Scholar PubMed PubMed Central

[79] Croft, M., Duan, W., Choi, H., Eun, S. Y, Madireddi, S., Mehta, A. (2012). TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol, 144-52.10.1016/j.it.2011.10.004Search in Google Scholar PubMed PubMed Central

[80] Xia, C., Braunstein, Z., Toomey, A. C., Zhong, J., Rao, X. (2018). S100 Proteins as an important regulator of macrophage inflammation. Front Immunol, 8, 1908.10.3389/fimmu.2017.01908Search in Google Scholar PubMed PubMed Central

[81] Wrobleski, S. T., Moslin, R., Lin, S., Zhang, Y., et. al. (2019). Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165. J Med Chem, 62, 8973-8995.10.1021/acs.jmedchem.9b00444Search in Google Scholar PubMed

[82] Norman, P. (2012). Selective JAK1 inhibitor and selective Tyk2 inhibitor patents. Expert Opin Ther Pat, 22, 1233-1249.10.1517/13543776.2012.723693Search in Google Scholar PubMed